Pharmacielo Shares Outstanding vs. Price To Book
| PCLO Stock | CAD 0.13 0.01 7.14% |
For Pharmacielo profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Pharmacielo to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Pharmacielo utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Pharmacielo's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Pharmacielo over time as well as its relative position and ranking within its peers.
Pharmacielo |
Pharmacielo Price To Book vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Pharmacielo's current stock value. Our valuation model uses many indicators to compare Pharmacielo value to that of its competitors to determine the firm's financial worth. Pharmacielo is considered to be number one stock in shares outstanding category among its peers. It also is considered to be number one stock in price to book category among its peers . The ratio of Shares Outstanding to Price To Book for Pharmacielo is about 17,906,157 . Price To Book Ratio is likely to climb to -16.3 in 2024. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pharmacielo's earnings, one of the primary drivers of an investment's value.Pharmacielo Price To Book vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Pharmacielo |
| = | 169.74 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Pharmacielo |
| = | 9.48 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Pharmacielo Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Pharmacielo, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Pharmacielo will eventually generate negative long term returns. The profitability progress is the general direction of Pharmacielo's change in net profit over the period of time. It can combine multiple indicators of Pharmacielo, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 30.5 M | 24.3 M | |
| Operating Income | -10 M | -10.5 M | |
| Net Loss | -16.3 M | -17.1 M | |
| Income Before Tax | -16.3 M | -17.1 M | |
| Total Other Income Expense Net | -3.4 M | -3.2 M | |
| Net Loss | -24 M | -25.2 M | |
| Net Loss | -16.3 M | -17.1 M | |
| Income Tax Expense | 1.7 M | 1.8 M | |
| Net Interest Income | -2.9 M | -2.7 M | |
| Interest Income | 176.00 | 167.20 | |
| Change To Netincome | 14.8 M | 12.8 M | |
| Net Loss | (0.10) | (0.11) | |
| Income Quality | 0.32 | 0.30 | |
| Net Income Per E B T | 0.99 | 0.82 |
Pharmacielo Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Pharmacielo. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Pharmacielo position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Pharmacielo's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Pharmacielo without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Use Investing Themes to Complement your Pharmacielo position
In addition to having Pharmacielo in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Gold and Gold Mining Thematic Idea Now
Gold and Gold Mining
Large and mid-size companies, ETFs and funds that are either investing, exploring or producing, gold or indirectly involved in trading or making gold products. The Gold and Gold Mining theme has 100 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gold and Gold Mining Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Pharmacielo Stock Analysis
When running Pharmacielo's price analysis, check to measure Pharmacielo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmacielo is operating at the current time. Most of Pharmacielo's value examination focuses on studying past and present price action to predict the probability of Pharmacielo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmacielo's price. Additionally, you may evaluate how the addition of Pharmacielo to your portfolios can decrease your overall portfolio volatility.